Tomasz Karol Książek
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tomasz Karol Książek has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Aleksandra Szeliga
Medical Univeristy of Białystok, Jana Kliniśkiego 1 street, 15-089 Białystok, Poland
9 shared publications - Anna Ewelina Francuziak
University Hospital in Krakow
9 shared publications - Kinga Kozłowska
Provincial Hospital of Podkarpackie John Paul II in Krosno
9 shared publications - Maciej Borowski
Univeristy Clinical Hospital of Bialystok
9 shared publications - Michał Szczepański
Jedrzej Sniadecki Regional Hospital in Białystok
9 shared publications - Natalia Dzieszko
Jedrzej Sniadecki Regional Hospital in Białystok
9 shared publications
Latest Publications
- Open Access
- 13 November 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 45, 66502
Incidence of deformity recurrence after surgical treatment of hallux valgus toe - risk factors and prevention
Introduction: Hallux valgus (HV) is a prevalent forefoot deformity, defined by lateral deviation of the great toe and medial displacement of the first metatarsal. When conservative measures fail, surgical correction is often required. Despite numerous refined techniques, postoperative recurrence remains a significant clinical challenge, with rates varying depending on the procedure and patient-specific factors. Aim: This review systematically evaluates the incidence of HV recurrence after surgery, identifies anatomical, radiographic, and procedural risk factors, and assesses strategies to prevent relapse and optimize long-term outcomes. Methods: A comprehensive literature review was conducted using PubMed, Google Scholar, Scopus, and ResearchGate. Results and Conclusion: HV recurrence is influenced by multiple factors, particularly pre- and postoperative radiographic parameters such as hallux valgus angle (HVA), intermetatarsal angle (IMA), and sesamoid position. Effective prevention relies on individualized surgical planning, precise correction of deformities, and structured postoperative management, including physiotherapy and appropriate footwear. Recognizing modifiable risk factors and applying evidence-based strategies can reduce recurrence rates and improve patient satisfaction, highlighting the importance of tailored long-term care in HV management.
- 13 November 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 45, 66502
Open AccessIncidence of deformity recurrence after surgical treatment of hallux valgus toe - risk factors and prevention
Introduction: Hallux valgus (HV) is a prevalent forefoot deformity, defined by lateral deviation of the great toe and medial displacement of the first metatarsal. When conservative measures fail, surgical correction is often required. Despite numerous refined techniques, postoperative recurrence remains a significant clinical challenge, with rates varying depending on the procedure and patient-specific factors. Aim: This review systematically evaluates the incidence of HV recurrence after surgery, identifies anatomical, radiographic, and procedural risk factors, and assesses strategies to prevent relapse and optimize long-term outcomes. Methods: A comprehensive literature review was conducted using PubMed, Google Scholar, Scopus, and ResearchGate. Results and Conclusion: HV recurrence is influenced by multiple factors, particularly pre- and postoperative radiographic parameters such as hallux valgus angle (HVA), intermetatarsal angle (IMA), and sesamoid position. Effective prevention relies on individualized surgical planning, precise correction of deformities, and structured postoperative management, including physiotherapy and appropriate footwear. Recognizing modifiable risk factors and applying evidence-based strategies can reduce recurrence rates and improve patient satisfaction, highlighting the importance of tailored long-term care in HV management.
- Open Access
- 13 November 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 45, 66522
Effects of systemic and local cryotherapy on the course of neurodegenerative and autoimmune diseases - A Literature Review
Introduction and Purpose: Cryotherapy, both systemic and local, is increasingly recognized as a complementary method in the treatment of inflammatory, autoimmune, and neurodegenerative diseases. This review aims to summarize current knowledge on the mechanisms of cryotherapy and its impact on clinical outcomes and biomarkers in selected chronic conditions. Description of state of knowledge Cryotherapy exerts anti-inflammatory effects by lowering levels of cytokines such as TNF-α, IL-1β, and IL-6. It also improves microcirculation, modulates hormonal responses and neurotransmission, contributing to pain relief, reduced fatigue, less joint stiffness, and improved quality of life. However, possible side effects include frostbite, dizziness, cold-induced urticaria, and transient hypertension. Contraindications include cardiovascular diseases, cryoglobulinaemia, and cold hypersensitivity. Methods: The literature review included studies from 2000–2025 in databases such as PubMed, Scopus, Web of Science, and Google Scholar. Clinical trials, systematic reviews, and meta-analyses evaluating the efficacy and safety of WBC and LBC were analysed. Conclusions: Cryotherapy is a valuable adjunctive tool for the treatment of diseases with a chronic course and inflammatory components, but its use should be preceded by detailed clinical assessment and patient qualification. Further randomised clinical trials are needed to establish optimal therapeutic protocols and an accurate safety profile.
- 13 November 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 45, 66522
Open AccessEffects of systemic and local cryotherapy on the course of neurodegenerative and autoimmune diseases - A Literature Review
Introduction and Purpose: Cryotherapy, both systemic and local, is increasingly recognized as a complementary method in the treatment of inflammatory, autoimmune, and neurodegenerative diseases. This review aims to summarize current knowledge on the mechanisms of cryotherapy and its impact on clinical outcomes and biomarkers in selected chronic conditions. Description of state of knowledge Cryotherapy exerts anti-inflammatory effects by lowering levels of cytokines such as TNF-α, IL-1β, and IL-6. It also improves microcirculation, modulates hormonal responses and neurotransmission, contributing to pain relief, reduced fatigue, less joint stiffness, and improved quality of life. However, possible side effects include frostbite, dizziness, cold-induced urticaria, and transient hypertension. Contraindications include cardiovascular diseases, cryoglobulinaemia, and cold hypersensitivity. Methods: The literature review included studies from 2000–2025 in databases such as PubMed, Scopus, Web of Science, and Google Scholar. Clinical trials, systematic reviews, and meta-analyses evaluating the efficacy and safety of WBC and LBC were analysed. Conclusions: Cryotherapy is a valuable adjunctive tool for the treatment of diseases with a chronic course and inflammatory components, but its use should be preceded by detailed clinical assessment and patient qualification. Further randomised clinical trials are needed to establish optimal therapeutic protocols and an accurate safety profile.
- Open Access
- 12 November 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 45, 66515
Hyperuricemia and Cardiovascular Disease: Mechanisms, Associations, and Therapeutic Implications – A Literature Review
Uric acid has emerged as a potential biomarker for cardiovascular risk. Hyperuricemia, described as an abnormally elevated concentration of uric acid in the bloodstream, has been associated with the development of cardiovascular diseases such as hypertension, atrial fibrillation, heart failure, and coronary heart disease. Recent studies have investigated the potential benefits of using uric acid-lowering therapy in slowing the progression of these diseases. In this review, we summarize current evidence on the impact of hyperuricemia on cardiovascular diseases and the effectiveness of urate-lowering therapy in affected patients.
- 12 November 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 45, 66515
Open AccessHyperuricemia and Cardiovascular Disease: Mechanisms, Associations, and Therapeutic Implications – A Literature Review
Uric acid has emerged as a potential biomarker for cardiovascular risk. Hyperuricemia, described as an abnormally elevated concentration of uric acid in the bloodstream, has been associated with the development of cardiovascular diseases such as hypertension, atrial fibrillation, heart failure, and coronary heart disease. Recent studies have investigated the potential benefits of using uric acid-lowering therapy in slowing the progression of these diseases. In this review, we summarize current evidence on the impact of hyperuricemia on cardiovascular diseases and the effectiveness of urate-lowering therapy in affected patients.
- Open Access
- 11 November 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 45, 66514
The Role of Creatine in Enhancing Bone Health Among Postmenopausal Women
Given the high popularity of creatine as a dietary supplement, its pleiotropiceffects, and its well-established safety profile, it is worth considering as an adjuncttherapy for osteoporosis—a condition that predominantly affects postmenopausalwomen due to hormonal changes, particularly a decline in estrogen levels—and hasbecome a silent epidemic of the 21st century. Creatine may indirectly enhance musclemass and strength, leading to increased mechanical stress on bones, and some studiessuggest that creatine might also directly influence osteoblast activity and bonemetabolism, potentially promoting bone formation. These direct and indirectmechanisms may improve bone health in at-risk women, reducing the risk of falls andfractures and ultimately contributing to a better quality of life. This research exploresthe effects of creatine on bone remodeling, metabolic activity, resistance trainingperformance, and its potential anti-inflammatory properties in the context of skeletalhealth maintenance. It also examines appropriate creatine dosing in older adults—whichtypically does not require a loading phase—and evaluates the safety of creatine use inaging women.
- 11 November 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 45, 66514
Open AccessThe Role of Creatine in Enhancing Bone Health Among Postmenopausal Women
Given the high popularity of creatine as a dietary supplement, its pleiotropiceffects, and its well-established safety profile, it is worth considering as an adjuncttherapy for osteoporosis—a condition that predominantly affects postmenopausalwomen due to hormonal changes, particularly a decline in estrogen levels—and hasbecome a silent epidemic of the 21st century. Creatine may indirectly enhance musclemass and strength, leading to increased mechanical stress on bones, and some studiessuggest that creatine might also directly influence osteoblast activity and bonemetabolism, potentially promoting bone formation. These direct and indirectmechanisms may improve bone health in at-risk women, reducing the risk of falls andfractures and ultimately contributing to a better quality of life. This research exploresthe effects of creatine on bone remodeling, metabolic activity, resistance trainingperformance, and its potential anti-inflammatory properties in the context of skeletalhealth maintenance. It also examines appropriate creatine dosing in older adults—whichtypically does not require a loading phase—and evaluates the safety of creatine use inaging women.
- Open Access
- 11 November 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 45, 66468
L-Citrulline and L-Arginine Supplementation in Cardiovascular and Exercise Physiology - A Comprehensive Review on Endothelial Function, Blood Pressure, and Physical Performance
Introduction and Purpose: L-citrulline and L-arginine are amino acids involved in nitric oxide (NO) synthesis, which plays a vital role in regulating vascular tone, arterial pressure, and exercise-induced physiological responses. This review aims to assess the effectiveness of L-citrulline and L-arginine supplementation in improving endothelial function, lowering blood pressure, and enhancing physical performance in both healthy and clinical populations. Brief Description of the State of Knowledge: Forty-three studies were included, ranging from randomized controlled trials to mechanistic investigations involving athletes, hypertensive patients, older adults, and postmenopausal women. L-citrulline demonstrated superior bioavailability compared to L-arginine and more effectively increased plasma arginine concentrations. Both supplements were associated with improved endothelial-dependent vasodilation and moderate blood pressure reductions, especially at daily doses ≥6 g. Some studies also reported benefits in VO₂ kinetics, reduced perceived exertion, and enhanced exercise tolerance. However, the results concerning measurable performance improvements remain inconsistent and context-specific. Conclusions: Supplementation with L-citrulline and L-arginine may offer non-pharmacological support for vascular health and exercise efficiency, particularly in individuals with endothelial dysfunction. Further studies are warranted to determine optimal dosing strategies and identify the populations most likely to benefit.
- 11 November 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 45, 66468
Open AccessL-Citrulline and L-Arginine Supplementation in Cardiovascular and Exercise Physiology - A Comprehensive Review on Endothelial Function, Blood Pressure, and Physical Performance
Introduction and Purpose: L-citrulline and L-arginine are amino acids involved in nitric oxide (NO) synthesis, which plays a vital role in regulating vascular tone, arterial pressure, and exercise-induced physiological responses. This review aims to assess the effectiveness of L-citrulline and L-arginine supplementation in improving endothelial function, lowering blood pressure, and enhancing physical performance in both healthy and clinical populations. Brief Description of the State of Knowledge: Forty-three studies were included, ranging from randomized controlled trials to mechanistic investigations involving athletes, hypertensive patients, older adults, and postmenopausal women. L-citrulline demonstrated superior bioavailability compared to L-arginine and more effectively increased plasma arginine concentrations. Both supplements were associated with improved endothelial-dependent vasodilation and moderate blood pressure reductions, especially at daily doses ≥6 g. Some studies also reported benefits in VO₂ kinetics, reduced perceived exertion, and enhanced exercise tolerance. However, the results concerning measurable performance improvements remain inconsistent and context-specific. Conclusions: Supplementation with L-citrulline and L-arginine may offer non-pharmacological support for vascular health and exercise efficiency, particularly in individuals with endothelial dysfunction. Further studies are warranted to determine optimal dosing strategies and identify the populations most likely to benefit.
- Open Access
- 11 November 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 45, 66480
Cutaneous complications in diabetes mellitus: pathophysiology, clinical relevance and the role of physical activity in prevention – a literature review
Diabetes mellitus is a chronic metabolic disease leading to a number of complications, including skin lesions, which may be the first sign of hyperglycaemia or indicative of advanced disease. In recent years, increasing attention has been paid to the role of physical activity not only in improving glycaemic control, but also in reducing the pathophysiological processes responsible for the cutaneous manifestations of diabetes. The aim of this study was to present the most common cutaneous lesions in patients with diabetes, their mechanisms of formation and to assess the impact of physical activity on their occurrence and course.
- 11 November 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 45, 66480
Open AccessCutaneous complications in diabetes mellitus: pathophysiology, clinical relevance and the role of physical activity in prevention – a literature review
Diabetes mellitus is a chronic metabolic disease leading to a number of complications, including skin lesions, which may be the first sign of hyperglycaemia or indicative of advanced disease. In recent years, increasing attention has been paid to the role of physical activity not only in improving glycaemic control, but also in reducing the pathophysiological processes responsible for the cutaneous manifestations of diabetes. The aim of this study was to present the most common cutaneous lesions in patients with diabetes, their mechanisms of formation and to assess the impact of physical activity on their occurrence and course.
- Open Access
- 11 November 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 45, 66476
Effect of Gastrointestinal Microbiota and Probiotics/Prebiotics in the Diet on the Development of Alzheimer's Disease – A Comprehensive Review
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by memory loss, cognitive decline, and behavioral changes, affecting over 50 million people worldwide. Its etiology involves complex genetic and environmental factors, and recent evidence implicates the gut–brain axis in disease progression. Dysbiosis of the gastrointestinal microbiota has been linked to increased neuroinflammation and accumulation of amyloid-β (Aβ) plaques and neurofibrillary tau tangles, the hallmark pathologies of AD. Conversely, beneficial gut bacteria produce metabolites (such as short-chain fatty acids, SCFAs) that may counteract these processes. This review summarizes current knowledge on how dietary interventions (probiotics and prebiotics) modulate the gut microbiota and influence AD pathology. Studies indicate that probiotic strains (notably Lactobacillus and Bifidobacterium) and prebiotics have potential to improve cognitive function and reduce neuroinflammation in preclinical and clinical settings. However, studies vary in design and scale, and therapeutic protocols are not yet standardized. Further research is needed to establish efficacy, dosage, and safety of microbiota-targeted interventions. Modulating the gut microbiota thus represents a novel avenue for AD prevention and treatment, although conclusive clinical evidence is still emerging.
- 11 November 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 45, 66476
Open AccessEffect of Gastrointestinal Microbiota and Probiotics/Prebiotics in the Diet on the Development of Alzheimer's Disease – A Comprehensive Review
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by memory loss, cognitive decline, and behavioral changes, affecting over 50 million people worldwide. Its etiology involves complex genetic and environmental factors, and recent evidence implicates the gut–brain axis in disease progression. Dysbiosis of the gastrointestinal microbiota has been linked to increased neuroinflammation and accumulation of amyloid-β (Aβ) plaques and neurofibrillary tau tangles, the hallmark pathologies of AD. Conversely, beneficial gut bacteria produce metabolites (such as short-chain fatty acids, SCFAs) that may counteract these processes. This review summarizes current knowledge on how dietary interventions (probiotics and prebiotics) modulate the gut microbiota and influence AD pathology. Studies indicate that probiotic strains (notably Lactobacillus and Bifidobacterium) and prebiotics have potential to improve cognitive function and reduce neuroinflammation in preclinical and clinical settings. However, studies vary in design and scale, and therapeutic protocols are not yet standardized. Further research is needed to establish efficacy, dosage, and safety of microbiota-targeted interventions. Modulating the gut microbiota thus represents a novel avenue for AD prevention and treatment, although conclusive clinical evidence is still emerging.
- Open Access
- 12 July 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 43, 61483
Non-surgical Approaches in the Treatment of Lower Back Pain: A Review of Methods, Efficacy, and Safety
Low back pain (LBP) is among the most common musculoskeletal disorders globally, representing a leading cause of disability and healthcare expenditure. Its prevalence is expected to rise significantly in the coming decades, emphasizing the need for effective, evidence-based treatment strategies. This narrative review explores non-surgical approaches to LBP management, focusing on pharmacological and non-pharmacological therapies. It discusses the classification, pathophysiology, and red flag symptoms, alongside an evaluation of conservative treatments including NSAIDs, acetaminophen, muscle relaxants, opioids, antidepressants, physical therapy, acupuncture, spinal manipulation, and psychosocial interventions. The findings indicate that NSAIDs offer modest short-term relief and remain first-line pharmacological agents, while acetaminophen has limited efficacy. Muscle relaxants may benefit acute cases but carry notable side effects, particularly in older adults. Opioids, though effective in the short term, show minimal long-term benefit and a high risk of dependence. Non-pharmacological treatments—especially exercise therapy, manual therapy, and cognitive-behavioral interventions—demonstrate consistent efficacy in reducing pain and improving function. In conclusion, optimal management of LBP necessitates an individualized, multimodal approach that integrates pharmacological options with physical and psychological strategies to minimize harm, enhance function, and address biopsychosocial contributors to pain.
- 12 July 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 43, 61483
Open AccessNon-surgical Approaches in the Treatment of Lower Back Pain: A Review of Methods, Efficacy, and Safety
Low back pain (LBP) is among the most common musculoskeletal disorders globally, representing a leading cause of disability and healthcare expenditure. Its prevalence is expected to rise significantly in the coming decades, emphasizing the need for effective, evidence-based treatment strategies. This narrative review explores non-surgical approaches to LBP management, focusing on pharmacological and non-pharmacological therapies. It discusses the classification, pathophysiology, and red flag symptoms, alongside an evaluation of conservative treatments including NSAIDs, acetaminophen, muscle relaxants, opioids, antidepressants, physical therapy, acupuncture, spinal manipulation, and psychosocial interventions. The findings indicate that NSAIDs offer modest short-term relief and remain first-line pharmacological agents, while acetaminophen has limited efficacy. Muscle relaxants may benefit acute cases but carry notable side effects, particularly in older adults. Opioids, though effective in the short term, show minimal long-term benefit and a high risk of dependence. Non-pharmacological treatments—especially exercise therapy, manual therapy, and cognitive-behavioral interventions—demonstrate consistent efficacy in reducing pain and improving function. In conclusion, optimal management of LBP necessitates an individualized, multimodal approach that integrates pharmacological options with physical and psychological strategies to minimize harm, enhance function, and address biopsychosocial contributors to pain.
- Open Access
- 10 July 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 43, 61492
Is Urate-lowering therapy a prevention of first gout episode?
The growing problem of gout is beginning to raise questions about how we can effectively prevent this disease. This work examines the effect of urate-lowering therapy on preventing the onset of a first episode of gout—an effect that is not entirely clear, despite the fact that such therapy is an essential tool for controlling gout flares. A growing database allows us to analyze the impact of hyperuricemia, which has so far been presumed to be a major contributor to the development of gout, and assess its actual impact on the development of the disease.
- 10 July 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 43, 61492
Open AccessIs Urate-lowering therapy a prevention of first gout episode?
The growing problem of gout is beginning to raise questions about how we can effectively prevent this disease. This work examines the effect of urate-lowering therapy on preventing the onset of a first episode of gout—an effect that is not entirely clear, despite the fact that such therapy is an essential tool for controlling gout flares. A growing database allows us to analyze the impact of hyperuricemia, which has so far been presumed to be a major contributor to the development of gout, and assess its actual impact on the development of the disease.